Summary Statement of Deficiencies D0000 An announced CLIA initial survey was conducted at Comprehensive Hematology Oncology LLC on 04/27/2021. The laboratory is not in compliance with 42 CFR Part 493, Requirements for Laboratories. The following is a description of the standard level deficiencies: D5781
π Unlock Deficiency Summary
Get full access to the detailed deficiency summary for this facility